Clinical trial
A Post-marketing Surveillance (Pms) Study Of Safety And Effectiveness In Patients With Tigecycline Treatment
NCT01072539 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post-marketing Surveillance (Pms) Study Of Safety And Effectiveness In Patients With Tigecycline Treatment
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2010
- Completion date
- April 30, 2015
- Enrollment
- 3,172 (actual)
- Sites
- 36
Conditions
As the registry lists them; a condition with its own page is linked.
community-acquired bacterial pneumonia, complicated intra-abdominal infections, complicated skin and skin structure infections